DBVT · DBV Technologies S.A. · Investor Relations

$11.25 -0.51 (-4.34%)

Market Cap

$753.87M

62.85M

Volume · Sep 30 400.95K Avg daily vol (3M) 309.19K

Press releases and events scraped from the company’s investor relations website. Past events open our own call or event page when we host one; otherwise listings link to the original source.

Upcoming events

Date	Event	Type
2026-10-28 00:00 UTC	Q3 Quarterly Update	Event

Past events

Date	Event	Type
2026-09-15	H.C. Wainwright 28th Annual Global Investment	Event
2026-09-09	2026 Cantor Global Healthcare Conference	Conference
2026-07-29	First Half Quarterly Update	Event
2026-07-23	APA-AAI Conference 2026	Conference
2026-07-16	Earnings conference call (announced in 8-K)	Earnings call
2026-06-29	DBV Update Conference Call	Conference
2026-06-03	2026 Annual General Meeting	Shareholder meeting
2026-05-28	Eastern Allergy Conference	Conference
2026-05-19	H.C. Wainwright BioConnect Conference	Conference
2026-04-30	Q1 Quarterly Update	Event
2026-03-10	The Citizens Life Sciences Conference	Conference
2026-02-27	American Academy of Allergy, Asthma & Immunology Annual Meeting 2026	Shareholder meeting
2026-02-12	Guggenheim Securities Emerging Outlook: Biotech Summit	Event
2025-12-16	VITESSE Topline Results Conference Call	Earnings call
2025-11-11	DBV Technologies to Participate in the Guggenheim Second Annual Healthcare Innovation Conference	Conference
2025-09-09	DBV Technologies to Participate in the H.C. Wainwright 27th Annual Global Investment Conference	Conference

Source: https://www.dbv-technologies.com/

Key facts CIK 1613780 CUSIP 23306J309 13F (30d) 3 filings 3 filers Visit website Investor relations